Immunotherapy Treatment Can Ease Symptoms from Allergen Exposure
For people with asthma and rhino-conjunctivitis, allergen immunotherapy (AIT) can reduce symptoms...
Read MoreNov 14, 2022
For people with asthma and rhino-conjunctivitis, allergen immunotherapy (AIT) can reduce symptoms...
Read MoreDec 21, 2021
Given the widespread prevalence of allergic disease, the significant clinical and economic burden associated with it, the unique disease-modifying benefits of allergy immunotherapy (AIT), and the increased availability of...
Read MoreNov 12, 2021
With the approval of sublingual allergen-specific immunotherapy (SL-AIT) tablets for grass and ragweed pollen by the Food and Drug Administration, SL-AIT is gaining traction in Europe, the United States, and other places. Based...
Read MoreMar 17, 2021
Researchers conducted this study to review OAS. The researchers searched several medical literature databases with the following keywords: “oral allergy syndrome,” “OAS,” “pollen-food allergy syndrome,” “PFAS,” “allergy,”...
Read MoreMar 16, 2020
New research was to be presented at AAAAI 2020, the American Academy of Allergy Asthma &...
Read More